Filing Details

Accession Number:
0001209191-20-031546
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-21 21:32:22
Reporting Period:
2020-05-19
Accepted Time:
2020-05-21 21:32:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1781983 Aprea Therapeutics Inc. APRE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219014 M Scott Rocklage 535 Boylston St
Boston MA 02116
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-19 244,800 $35.15 2,173,748 No 4 S Indirect see footnotes
Common Stock Disposition 2020-05-19 10,200 $35.15 90,572 No 4 S Indirect see footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect see footnotes
No 4 S Indirect see footnotes
Footnotes
  1. Shares are held directly by 5AM Ventures IV, L.P.
  2. The reporting person is a managing member of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM Funds. The reporting person disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM Funds, except to the extent of his pecuniary interest therein.
  3. Shares are held directly by 5AM Co-Investors IV, L.P